Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects

Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects

Abstract Background A once-daily (o.d.) fixed-dose combination of indacaterol acetate (IND), glycopyrronium bromide (GLY), and mometasone furoate (MF) delivered via the Breezhaler® device (IND/GLY/MF) is being developed for treatment of asthma. This study compared steady-state pharmacokinetics of IN...

Full description

Bibliographic Details
Main Authors: Satoru Inoue, Soniya Vaidya, Hanns-Christian Tillmann, Yohei Sakita, Surendra Machineni, Olivier Heudi, Kenichi Furihata
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Pulmonary Medicine
Subjects:
Indacaterol/glycopyrronium/mometasone furoate
Pharmacokinetics
Japanese–Caucasian
Asthma
Online Access:https://doi.org/10.1186/s12890-020-01382-6

Internet

https://doi.org/10.1186/s12890-020-01382-6

Similar Items